Literature DB >> 14621030

Breakthrough in the management of visceral leishmaniasis.

B B Thakur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14621030

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN： 0004-5772


× No keyword cloud information.
  4 in total

1.  The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro.

Authors:  N K Verma; C S Dey
Journal:  Diabetologia       Date:  2006-05-03       Impact factor: 10.122

Review 2.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

3.  Functional Involvement of Leishmania donovani Tryparedoxin Peroxidases during Infection and Drug Treatment.

Authors:  Sanchita Das; Sagnik Giri; Shyam Sundar; Chandrima Shaha
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 4.  The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.

Authors:  Peter Mubanga Cheuka; Godfrey Mayoka; Peggoty Mutai; Kelly Chibale
Journal:  Molecules       Date:  2016-12-31       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.